Home › Funds › HighVista Strategies LLC › AVTX

HighVista Strategies LLC position in AVTX

AVALO THERAPEUTICS INC · Health Care

HighVista Strategies LLC reported holding 176,673 shares of AVTX (AVALO THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$2.7M, representing 0.71% of its reported portfolio and ranking #45 among its reported holdings. HighVista Strategies LLC has disclosed AVTX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)176.67K sh
Reported value held$2.71M
Portfolio Weight0.71%
First reportedQ3 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How HighVista Strategies LLC's AVTX position evolved

HighVista Strategies LLC first disclosed a stake in AVTX in Q3 2025 at 27,778 shares (US$353K). The position peaked in Q3 2026 at 176,673 shares, worth US$2.7M. Across 5 filings, HighVista Strategies LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 176,673 shares valued at US$2.7M — an increase of 54,063 shares quarter over quarter.. Notable position changes include a 244% increase in Q4 2025 (shares fell 18% over the following quarter), a 109% increase in Q2 2026 (shares fell 17% over the following quarter), a 44% increase in Q3 2026 (shares fell 49% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 27.78K $353.06K New
Q4 2025 95.63K $1.74M Add
Q1 2026 58.62K $875.23K Reduce
Q2 2026 122.61K $2.27M Add
Q3 2026 176.67K $2.71M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AVTX and 13F data

AVTX (AVALO THERAPEUTICS INC) is a Health Care company. 80 other funds we track also report a position in AVTX — the largest reported positions include Deep Track Capital, LP (US$66.7M), Caligan Partners LP (US$58.5M), TCG Crossover Management, LLC (US$55.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AVTX

All AVTX fund holders →

FAQ

How long has HighVista Strategies LLC held AVTX?

HighVista Strategies LLC has disclosed AVTX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is HighVista Strategies LLC's current position in AVTX?

As of Q3 2026, HighVista Strategies LLC holds 176.67K shares of AVTX (AVALO THERAPEUTICS INC), valued at $2.71M, representing 0.71% of its reported portfolio and ranking #45.

Has HighVista Strategies LLC been buying or selling AVTX?

In the latest 13F filing (Q3 2026), HighVista Strategies LLC increased its position in AVTX. The position peaked in Q3 2026 at 176.67K shares.

Which other funds hold AVTX?

Other major institutional holders of AVTX include Deep Track Capital, LP, Caligan Partners LP, TCG Crossover Management, LLC, among 80 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.